Mahofski will be responsible for identifying and pursuing acquisition opportunities that complement RQM+’s core regulatory services and provide a comprehensive range of fully integrated outsourced solutions to help get MedTech products to market faster and ensure ongoing regulatory compliance.
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
Medtech businesses show tremendous potential for profitability and growth, triggering a sparked interest in investment.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Analysts expect 2020 to be a busy year for M&A activity.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
How will you make your company more attractive to investors?
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
The total value of deals for 2019 exceeds $30 billion.
Overall activity in deals jumped 11% in North America.